BioMarin Pharmaceutical Inc. (BMRN) Stock Overview
NASDAQ · Healthcare · Biotechnology
✓ Sourced directly from Yahoo Finance · Checked for accuracy at every rebuild · Snapshot: 6 September 2026
About BioMarin Pharmaceutical Inc.
BioMarin Pharmaceutical Inc., a biotechnology company, engages in the development and commercialization of therapies for life-threatening rare diseases and medical conditions in the United States, Europe, Latin America, the Middle East, the Asia Pacific, and internationally. The company's…
Source: Yahoo Finance
Sector & Industry
BioMarin Pharmaceutical Inc. operates in the Healthcare sector, within the Biotechnology industry group. It is listed on the NASDAQ exchange.
BioMarin Pharmaceutical Inc. at a Glance
| Company | BioMarin Pharmaceutical Inc. |
| Ticker | BMRN |
| Exchange | NASDAQ |
| Currency | USD |
| Price | $66.53 |
| Market cap | $12.88B |
| P/E ratio (trailing) | 179.81 |
| EPS (trailing) | $0.37 |
| 52-week high | $70.98 |
| 52-week low | $49.26 |
| Dividend yield | — |
| Ex-dividend date | — |
| Beta | 0.24 |
| Return on equity (ROE) | 1.18% |
| Debt-to-equity | 66.47% |
| Average volume | 1.98M |
| Shares outstanding | 193.57M |
| Sector | Healthcare |
| Industry | Biotechnology |
| Employees | 3,221 |
| Country | United States |
Investing Essentials
As an Amazon Associate we earn from qualifying purchases. Links below are affiliate links.
Peter Lynch on how everyday investors can spot winners before the professionals do.
Check Price →Evaluating pharma pipelines, devices and healthcare economics.
Check Price →Benjamin Graham's classic on value investing — the book Warren Buffett calls the best ever written on the subject.
Check Price →Frequently Asked Questions
- What is BioMarin Pharmaceutical Inc.'s current P/E ratio?
- BioMarin Pharmaceutical Inc. (BMRN) has a trailing P/E ratio of 179.81 as of our 6 September 2026 data snapshot. Learn what the P/E ratio means →
- What is BioMarin Pharmaceutical Inc.'s market capitalisation?
- BioMarin Pharmaceutical Inc.'s market cap is $12.88B based on our latest snapshot. See how it ranks by market cap →
- What is BMRN's 52-week range?
- Over the past 52 weeks, BMRN has traded between $49.26 and $70.98. What does the 52-week range mean? →
- How volatile is BioMarin Pharmaceutical Inc. compared to the market?
- BioMarin Pharmaceutical Inc. has a beta of 0.24, meaning it has historically moved less than the broader market. What does beta measure? →
- Does BioMarin Pharmaceutical Inc. pay a dividend?
- BioMarin Pharmaceutical Inc. does not currently pay a dividend according to our latest data.
- What exchange is BMRN listed on?
- BMRN is listed on the NASDAQ. Browse all NASDAQ-listed stocks →
- What sector is BioMarin Pharmaceutical Inc. in?
- BioMarin Pharmaceutical Inc. is classified in the Healthcare sector. Compare with Healthcare peers →
Prefer raw numbers at a glance? Browse our size and reference charts for quick lookups.
Many readers keep a stock investing journal to log positions and theses alongside pages like this one, and a dedicated financial calculator to hand for quick valuation maths.
Recommended Reading & Tools
Philip Fisher on what makes a business worth owning for the long term.
Check Price →Burton Malkiel's evidence-based guide to markets, indexing and long-term strategy.
Check Price →Morgan Housel's short lessons on behaviour, luck and long-term wealth.
Check Price →